Hostname: page-component-77c89778f8-gq7q9 Total loading time: 0 Render date: 2024-07-19T19:12:40.016Z Has data issue: false hasContentIssue false
  • English
  • Français

Bipolar Disorders: Special Diagnostic and Treatment Considerations in Women

Published online by Cambridge University Press:  07 November 2014

Susan L. McElroy
Get access Rights & Permissions [Opens in a new window]

Abstract

Bipolar disorder in women presents special diagnostic and treatment challenges to the clinician. The presentation of female bipolar may resemble depressive disorders, comorbid Axis I disorders, Axis II personality disorders, behavioral dysregulation, or general medical disorders; thus, it is critically important for clinicians to assess for a history of hypomania or mania when determining diagnosis in any woman presenting with psychological symptoms. Several gender differences may exist in the epidemiology and symptomatology of bipolar disorder, and each must be kept in mind during assessment. Rapid cycling and mixed states have been associated with female gender and may present diagnostic challenges as each often presents as major depression. Symptoms of postpartum psychosis tend to differ from the symptoms typically seen in bipolar mania; therefore, if postpartum psychosis is actually a manifestation of bipolar disorder, accurate diagnosis depends upon a knowledge of these differences. Special treatment considerations for bipolar disorder in women involve interactions between the illness and the female reproductive cycle. A risk of fetal malformation exists when some mood-stabilizing agents are used during conception and/or during the first trimester of pregnancy. Neurobehavioral teratogenicity and neonatal toxicity is also possible. Careful treatment management is necessary to reduce the risks to the fetus/infant and to effectively manage bipolar disorder in the mother. In treating women with bipolar disorder, clinicians should discuss the issue of pregnancy and associated risks of treatment versus no treatment with every patient of reproductive age. Further studies are needed on gestational timing and exposure to mood-stabilizing agents, especially newer agents recently approved or currently being considered for the treatment of bipolar disorder.

Type
Academic Supplement
Information
CNS Spectrums , Volume 9 , supplement S7: Mood and Anxiety Disorders: Special Considerations in Women , August 2004 , pp. 5 - 18
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Thomas, P. The many forms of bipolar disorder: a modern look at an old illness. J Affect Disord. 2004;79(Suppl 1):S3–S8.Google Scholar
2. Akiskal, HS, Bourgeois, ML, Angst, J, Post, R, Moller, H, Hirschfeld, R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. 2000;59(Suppl 1):S5–S30.CrossRefGoogle ScholarPubMed
3. Kessler, RC, McGonagle, KA, Swam, M, Blazer, DG, Nelson, CB. Sex and depression in the National Comorbidity Survey I: lifetime prevalence, chronicity, and recurrence. J Affect Disord. 1993;29:77–84,85–96.CrossRefGoogle ScholarPubMed
4. Regier, DA, Boyd, JH, Burke, JD, et al. One-month prevalence of mental disorders in the United States. Arch Gen Psychiatry. 1988;45:977–986.CrossRefGoogle ScholarPubMed
5. Weissman, MM, Olfson, M. Depression in women: implications for health care research. Science. 1995;269:799–801.Google Scholar
6. Szádóczky, E, Papp, ZS, Vitrai, J, Rihmer, Z, Füredi, J. The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiological survey. J Affect Disord. 1998;50:153–162.Google Scholar
7. Angst, J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998;50:143–151.Google Scholar
8. Angst, J, Gamma, A, Benazzi, F, Ajdacic, V, Eich, D, Rössler, W. Toward a re-definition of subthreshold bipolarity: Epidemiology and proposed criteria for bipolar II, minor bipolar disorders and hypomania. J Affect Disord. 2003:73:133–146.Google Scholar
9. Judd, LL, Akiskal, HS. The prevalence and disability of bipolar spectrum disorders in the U.S. population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord. 2003;73:123–131.Google Scholar
10. Lewinsohn, PM, Klein, DN, Seeley, JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolescent Psychiatry. 1995;34:454–463.CrossRefGoogle Scholar
11. Chaudron, LH, Pies, RW. The relationship between postpartum psychosis and bipolar disorder: a review. J Clin Psychiatry. 2003;64:1284–1292.CrossRefGoogle ScholarPubMed
12. Wittchen, H-U, Nelson, CB, Lachner, G. Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychological Med. 1998;28:109–126.CrossRefGoogle ScholarPubMed
13. Akiskal, HS, Hantouche, EG, Allilaire, J-F, et al. Validating antidepressantassociated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). J Affect Disord. 2003:73:65–74.Google Scholar
14. Cassano, GB, Akiskal, HS, Savino, M, Musetti, L, Perugi, G. Proposed subtypes of bipolar II and related sisorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affect Disord. 1992;26:127–140.Google Scholar
15. Cassano, GB, Dell'Osso, L, Frank, E, et al. The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology. J Affect Disord. 1999;54:319–328.Google Scholar
16. Arnold, LM. Gender differences in bipolar disorder. Psychiatr Clin North Am. 2003;26:595–620.CrossRefGoogle ScholarPubMed
17. Benazzi, F. Sensitivity and specificity of clinical markers for the diagnosis of bipolar II disorder. Comprehensive Psychiatry. 2001:42:461–465.CrossRefGoogle ScholarPubMed
18. Benazzi, F, Akiskal, HS. Refining the evaluation of bipolar II: beyond the strict SC1D-CV guidelines for hypomania. J Affect Disord. 2003:73:33–38.CrossRefGoogle ScholarPubMed
19. Bowden, CL. Strategies to reduce misdiagnosis of bipolar depression. Psychiatt Serv. 2001;52(l):51–55.CrossRefGoogle ScholarPubMed
20. First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for the DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID1/P). NewYork, NY: Biometrics Research Department, New York State Psychiatric Institute; 2001.Google Scholar
21. Hirschfeld, RMA, Williams, JBW, Spitzer, RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157:1873–1875.CrossRefGoogle ScholarPubMed
22. Leibenluft, E. Women with bipolar illness: clinical and research issues. Am J Psychiatry. 1996;153(2):163–173.Google Scholar
23. Leibenluft, E. Issues in the treatment of women with bipolar illness. J Clin Psychiatry. 1997:58:5–11.Google Scholar
24. Leibenluft, E. Gender differences in major depressive disorder and bipolar disorder. CNS Spectr. 1999:4:25–33.CrossRefGoogle ScholarPubMed
25. Kupfer, DJ, Frank, E, Grochocinski, VJ, Cluss, PA, Houck, PR, Stapf, DA. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry. 2002;63:120–125.CrossRefGoogle Scholar
26. Angst, J. The course of affective disorders. II. Typology of bipolar manic-depressive illness. Archiv für Psychiairk Nervenkrankheiten. 1978;226:65–73.CrossRefGoogle ScholarPubMed
27. Angst, J, Sellaro, R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry. 2003:48:445–457.CrossRefGoogle Scholar
28. Robb, JC, Young, LT, Cooke, Joffe RT. Gender differences in patients with bipolar disorder influence outcome in the Medical Outcomes Survey (SF-20) Subscale Scores. J Affect Disord. 1998:49:189–193.CrossRefGoogle ScholarPubMed
29. Roy-Byrne, P, Post, RM, Uhde, TW, Porcu, T, Davis, D. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psych Scand. 1985;317(Suppl):S5–S32.Google Scholar
30. Hendrick, V, Altshuler, LL, Gitlin, MJ, Delrahim, S, Hammen, C. Gender and bipolar illness. J Clin Psychiatry. 2000;61:393–396.Google Scholar
31. Winokur, G, Coryell, W, Akiskal, HS, Endicott, J, Keller, M, Mueller, T. Manicdepressive (bipolar) disorder: the course in Light of a prospective ten-year followup of 131 patients. Acta Psych Scand. 1994:89:102–110.CrossRefGoogle ScholarPubMed
32. Ghaemi, SN, Sachs, GS, Chiou, AM, et al. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord. 1999;52:135–144.Google Scholar
33. Chen, Y-W, Dilsaver, SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biol Psychiatry. 1996;39:896–899.Google Scholar
34. Kessler, RC, Borges, G, Walters, EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999:56:617–626.Google Scholar
35. McElroy, SL, Keck, PE Jr, Pope, HG Jr, Hudson, J, Faedda, G, Swann, A. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry. 1992;149:1633–1644.Google ScholarPubMed
36. Calabrese, JR, Shelton, MD, Bowden, CL, et al. Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry. 2001;62(Suppl 14):34–41.Google Scholar
37. Dunner, DL. A two-illness model of bipolar disorder: a commentary. Bipolar Disord. 1999;1:36–37.CrossRefGoogle ScholarPubMed
38. Benazzi, F. Which could be a clinically useful definition of depressive mixed state? Prog Neuropsychopharmocol Biol Psychiatry. 2002;26(6):1105–1111.CrossRefGoogle ScholarPubMed
39. Kupka, RW, Luckenbaugh, DA, Post, RM, Leverich, GS, Nolen, WA. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry. 2003;64:1483–1494.Google Scholar
40. Thomas, P. The many forms of bipolar disorder: a modern look at an old illness. J Affect Disord. 2004;79(Suppl):S3–S8.CrossRefGoogle Scholar
41. Perugi, G, Akiskal, HS, Lattanzi, L, et al. The high prevalence of “soft” bipolar (II) features in atypical depression. Compr Psychiatry. 1998;39:63–71.CrossRefGoogle ScholarPubMed
42. Viguera, AC, Baldessarini, RJ, Tondo, L. Response to lithium maintenance treatment in bipolar disorders: comparison of women and men. Bipolar Disorders. 2001:3:245–252.Google Scholar
43. Yildiz, A, Sachs, GS. Age of onset of psychotic versus non-psychotic bipolar illness in men and in women. J Affect Disord. 2003:74:197–201.Google Scholar
44. Bellivier, F, Golmard, J-L, Chantal, H, Leboyer, M. Admixture analysis of age of onset in bipolar I affective disorder. Arch Gen Psychiatry. 2001;58:510–512.Google Scholar
45. Goodwin, FK, Jamison, KR. Manic Depressive Illness. New York, NY: Oxford University Press; 1990.Google Scholar
46. Suppes, T, Leverich, GS, Keck, PE Jr, et al. The Stanley Foundation Bipolar Treatment Outcome Network II. Demographics and illness characteristics of the first 261 patients. J Affect Disord. 2001:67:45–59.Google Scholar
47. Koukopulous, A, Sani, G, Koukopoulus, AE, et al. Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients. J Affect Disord. 2003;73:75–85.CrossRefGoogle Scholar
48. DelBello, MP, Carlson, GA, Tohen, M, Bromet, EJ, Schwiers, M, Strakowski, SM. Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features. J Child Adolescent Psychopharmacol. 2003;13:173–185.CrossRefGoogle ScholarPubMed
49. Frye, MA, Altshuler, LL, McElroy, SL, et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry. 2003;160:883–889.Google Scholar
50. Strakowski, SM, Tohen, M, Stoll, AL, Faedda, GL, Goodwin, DC. Comorbidity in mania at first hospitalization. Am J Psychiatry. 1992;149:554–556.Google Scholar
51. McElroy, SL, Altshuler, LL, Suppes, T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001:158:420–426.CrossRefGoogle ScholarPubMed
52. Blehar, MC, DePaulo, JR Jr, Gershon, ES, Reich, T, Simpson, SG, Nurnberger JI. Women with bipolar disorder: findings from the NIMH Genetics Initiative Sample. Psychopharmacol Bull. 1998;34:239–243.Google ScholarPubMed
53. Calabrese, JR, Hirschfeld, RMA, Reed, M, et al. Impact of bipolar disorder on a U.S. community sample. J Clin Psychiatry. 2003:64:425–432.CrossRefGoogle Scholar
54. Bauer, MS, Whybrow, PC, Winokur, A. Rapid cycling bipolar affective disorder. Association with grade I hypothyroidism. Arch Gen Psychiatry. 1990;47:427–432.Google Scholar
55. Cowdry, R, Wehr, T, Zis, A, Goodwin, F. Thryoid abnormalities associated with rapid cycling bipolar illness. Arch Gen Psychiatry. 1983;40:414–420.Google Scholar
56. Elmslie, J, Silverstone, J, Mann, J, Williams, S, Romans, S. Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry. 2000;61:179–184.Google Scholar
57. McEltoy, SL, Frye, MA, Suppes, T, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry. 2002;63(3):207–213.Google Scholar
58. Fagiolini, A, Kupfer, DJ, Houck, DM. Frank, E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry. 2003;160:112–117.CrossRefGoogle ScholarPubMed
59. Leverich, GS, McElroy, SL, Suppes, T, et al. Early physical and sexual abuse associated with an adverse xourse of bipolar illness. Biol Psychiatry. 2002;51:288–297.CrossRefGoogle ScholarPubMed
60. Hendrick, V, Altshuler, LL, Burt, VK. Course of psychiatric disorders across the menstrual cycle. Harv Rev Psychiatry. 1996;4:200–207.Google Scholar
61. Ota, Y, Mukai, T, Gotoda, K. Study on the relationship between psychiatric symptoms and sexual cycle. Folia Psychiatrica Neurol Japan. 1954:8:207–217.Google Scholar
62. Diamond, SB, Rubinstein, AA, Dunner, DL, Fieve, RR. Menstrual problems in women with primary affective illness. Compr Psychiatry. 1976;17:541–548.CrossRefGoogle ScholarPubMed
63. Conrad, CD, Hamilton, JA. Recurrent premenstrual decline in serum lithium concentrations: clinical correlates and treatment implications. J Am Acad Child Adolesc Psychiatry. 1986;26:852–853.Google Scholar
64. Rasgon, N, Bauer, M, Glenn, T, Elman, S, Whybrow, PC. Menstrual cycle related mood changes in women with bipolar disorder. Bipolar Disord. 2003;5:48–52.Google Scholar
65. Price, WA, DiMarzio, L. Premenstrual tension syndrome in rapid-cycling bipolar affective disorder. J Clin Psychiatry. 1986:47:415–417.Google ScholarPubMed
66. Wehr, TA, Sack, DA, Rosenthal, NE, Cowdry, RW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry. 1988:145:179–184.Google ScholarPubMed
67. Nonacs, R, Vigueta, AC, Cohen, LS. Psychiaric Aspects of Pregnancy in Women's Mental Health. A Comprehensive Textbook. Kornstein, SG, Clayton, AH, eds. New York, NY: The Guilford Press; 2002:70–90.Google Scholar
68. Klompenhouwer, JL, van Hulst, AM. Classification of postpattum psychosis: a study of 250 mothe rand baby admissions in The Netherlands. Acta Psychiatr Scand. 1991;84(3):255–261.Google Scholar
69. Diagnostic and Statistical Manual of Mental Disorders. 4th ed text rev. Washington, DC: Ametican Psychiatric Publishing, Inc; 2000:422–423.Google Scholar
70. Hamilton, JA. Postpartum psychiatric syndromes. Psychiatr Clin North Am. 1989;12:89–103.Google Scholar
71. Brockington, IF, Cernik, KF, Schofield, EM, et al. Puerperal psychosis: phenomena and diagnosis. Arch Gen Psychiatry. 1981:38:829–833.Google Scholar
72. Foundeur, M, Fixser, C. Triebel, WA, et al. Postpartum mental illness: a controlled study. Arch Neurol Psychiatry. 1957:77:508–512.Google Scholar
73. Jones, I, Craddock, N. Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry. 2001;158(6):913–917.Google Scholar
74. Attia, E, Downey, J, Obetman, M. Postpartum psychoses. In: Miller, LJ, ed. Postpartum Mood Disorders. Washington, DC: American Psychiatric Press, Inc; 1999:3–20.Google Scholar
75. Freeman, MP, Smith, KW, Freeman, SA, et al. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry. 2002;63(4):284–287.CrossRefGoogle ScholarPubMed
76. Ishimaru-Tseng, TV. Evaluation of late onset bipolar illness during menopause. Hawaii Med J. 2000;59(2):51–53.Google ScholarPubMed
77. Koukopoulos, A, Minnai, GP, Müller-Oerlinghausen, B. The influence of mania and depression on the pharmacokinetics of lithium: a longitudinal single-case study. J Affect Disord. 1985;8(2):159–166.Google Scholar
78. Chamberlain, S, Hahn, PM, Casson, P, Reid, RL. Effect of menstrual cycle phase and oral contraceptive use on serum lithium levels after a loading dose of lithium in normal women. Am J Psychiatry. 1990;147(7):907–909.Google Scholar
79. Yonkers, KA, Wisner, KL, Stowe, Z, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry. 2004;161(4):608–620.CrossRefGoogle ScholarPubMed
80. Nora, JJ, Nora, AH, Toews, WH. Lithium, Ebstein's anomaly, and other congenital heart defects [letter]. Lancet. 1974;2(7880):594–595.CrossRefGoogle ScholarPubMed
81. Schou, M, Goldfield, MD, Weinstein, MR, Villeneuve, A. Lithium and ptegnancy. I. Report from the register of lithium babies. Br Med J. 1973;2(5859):135–136.CrossRefGoogle ScholarPubMed
82. Edmonds, LD, Oakley, GP. Ebstein's anomaly and maternal lithium exposure during pregnancy. Tetratology. 1990:41:551–552.Google Scholar
83. Jacobson, SJ, Jones, K, Johnson, K, et al. Prospective multicentte study of ptegnancy outcome aftet lithium exposure during first trimester. Lancet. 1992;339(8792):530–533.Google Scholar
84. Cohen, LS, Friedman, JM, Jefferson, JW, Johnson, EM, Weiner, ML. A reevaluation of risk of in utero exposure to lithium. JAMA. 1994;271(2):146–150.Google Scholar
85. Altshuler, LL, Cohen, L, Szuba, MP, Burt, VK, Gitlin, M, Mintz, J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry. 1996;153:592–606.Google ScholarPubMed
86. Ananth, J. Side effects in the neonate from psychotropic agents excreted through breast-feeding. Am J Psychiatry. 1978;135(7):801–805.Google Scholar
87. Schou, M, Amdisen, A. Lithium ingestion by children breast-fed by women on lithium treatment. Br Med J. 1973;2(5859):138.Google Scholar
88. Nars, PW, Girard, J. Lithium carbonate intake during pregnancy leading to large goiter in a premature infant. Am J Dis Child. 1977;131(8):924–925.Google Scholar
89. Mizrahi, EM, Hobbs, JF, Goldsmith, DI. Nephrogenic diabetes insipidus in transplacental lithium intoxication. J Pediatr. 1979;94(3):493–495.Google Scholar
90. Goldfield, MD, Weinstein, MR. Lithium carbonate in obstetrics: guidelines for clinical use. Am J Obstet Gynecol. 1973;116:15–22.CrossRefGoogle ScholarPubMed
91. Schou, M, Amdisen, A, Steenstrup, OR. Lithium and pregnancy, Il: hazards to women given lithium during pregnancy and delivery. Br Med J. 1973:2:137–138.Google Scholar
92. Weinstein, MR. Lithium treatment of women during pregnancy and in the postdelivery period. In: Handbook of Uthium Therapy. Johnson, FN, ed. Baltimore, MD: University Park Press; 1980:421–429.Google Scholar
93. Viguera, AC, Nonacs, R, Cohen, LS, Tondo, L, Murray, A, Baldesarini, RJ. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women aftet discontinuing lithium maintenance. Am J Psychiatry. 2000:157:179–184.Google Scholar
94. Crawford, P, Appleton, R, Betts, T, Duncan, J, Guthrie, E, Morrow, J. Best practice guidelines for the management of women with epilepsy. Seizure. 1999:8:201–217.CrossRefGoogle ScholarPubMed
95. Nakane, Y, Okuma, T, Takahashi, R. Multi-institutional study on tetatogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia. 1980:21:663–680.Google Scholar
96. Jones, KL, Lacro, RV, Johnson, KA, Adams, J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med. 1989;320:1661–1666.CrossRefGoogle ScholarPubMed
97. Lindhout, D, Omtzigt, J. Teratogenic effects of antiepileptic dtugs: implications for the management of epilepsy in women of childbearing age. Epilepsia. 1994;35(Suppl):S19–S28.CrossRefGoogle Scholar
98. Delgado-Escueta, A, Janz, D. Consensus guidelines: preconception counseling, management, and care of pregnant women wiThepilepsy. Neurology. 1992;42:149–160.Google Scholar
99. Karceski, S, Morrell, M, Carpenter, D. The Expert Consensus Guidelines Series: treatment of epilepsy. Epilepsy Behav. 2001;2:A1–A50.Google Scholar
100. American Academy of Neurology: Practice Patameter: Management Issues for Wome n Wit h Epilepsy (Summary Statement): report of the Quality Standard Subcommittee of the American Academy of Neurology. Neurology. 1998;51:944–948.Google Scholar
101. Nau, H, Kuhnz, W, Egger, H, Rating, D, Hedge, H. Anticonvulsants during pregnancy and lactation: transplacental, maternal and neonatal pharmacokinetics. Clin Pharmocoldnet. 1982:6:508–543.CrossRefGoogle Scholar
102. Briggs, G, Freeman, R, Yaffe, S. Drugs in Pregnancy and Lactation. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.Google Scholar
103. Tran, TA, Leppik, IE, Blesi, K, Sathanandan, ST, Remmel, R. Lamotrigine clearance during pregnancy. Neurology. 2002;59:251–255.Google Scholar
104. Pennel, PB, Montgomery, JQ, Clements, SD, Newport, DJ. Lamotrigine clearance markedly increases during pregnancy [abstract]. Epilepsia. 2002;43(Suppl 7):234.Google Scholar
105. Van Waes, A, Van de Velde, E. Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum. J Clin Pharmacol. 1969;9:224–227.Google Scholar
106. Altshuler, LL, Cohen, L, Szuba, MP, Burt, VK, Gitlin, M, Mintz, J. Phamacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry. 1996;153:592–606.Google Scholar
107. Ayd, F. Is psychiatry in a crisis because of the complications of the psychopharmaceuticals. Dis Nerv Syst. 1968;29:23–25.Google Scholar
108. Hammond, J, Toseland, P. Placental transfer of chlorpromazine. Arch Child Dis. 1970;45:139–140.Google Scholar
109. McElroy, S, Keck, P, Stanton, S, Turgrul, K, Bennett, J, Strakowski, S. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry. 1996;57:142–146.Google Scholar
110. Goldstein, D. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol. 2000;20:399–403.Google Scholar
111. Littrell, KH, Johnson, CG, Peabody, CD, Hilligoss, N. Antipsychotics during pregnancy ]Letter]. Am J Psychiatry. 2000;157:1342.Google Scholar
112. Kirchheiner, J, Berghofer, A, Bolk-Weischedel, D. Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry. 2000;33:78–80.Google Scholar
113. Dolovich, LR, Addis, A, Vaillancourt, J, et al. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. Br Med J Clin Res Ed. 1998;317:839–843.Google Scholar
114. Laegreid, L, Olegard, R, Wahlstrom, J, Conradi, N. Abnormalities in children exposed to benzodiazepines in utero [Letter]. Lancet. 1987; 1:108–109.Google Scholar
115. Weinstock, L. Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series. Psychother Psychosom. 1996;70:158–162.Google Scholar
116. Nakane, Y, Okuma, T, Takahashi, R. Multi-institutional atudy on reratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epikpsia. 1980;21:663–680.Google Scholar
117. Cohen, LS, Friedman, JM, Jefferson, JW, Johnson, EM, Weiner, ML. A reevaluation of risk of in utero exposure to lithium. JAMA. 1994;271(2): 146–150.Google Scholar
118. Viguera, AC, Cohen, LS. The course and management of bipolar disorder during pregnancy. Psychopharmacol Bull. 1998;34:339–346.Google ScholarPubMed
119. Wisner, KL, Zarin, D, Holmboe, E, et al. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry. 2000;157:1933–1940.Google Scholar
120. Laegreid, L, Kyllerman, M, Hedner, T, Hagberg, B, Viggedahl, G. Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy. Neumpediatrics. 1993;24:88–92.CrossRefGoogle ScholarPubMed
121. Stewart, DE, Klompenhouwer, JL, Kendell, RE, van Hulst, AM. Prophylactic lithium in puerperal psychosis: the experience of three centers. Br J Psychiatry. 1991;158:393–397.Google Scholar
122. Cohen, LS, Sichel, DA, Robertson, LM, Heckscher, E, Rosenbaum, JF. Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry. 1995;152:1641–1645.Google Scholar
123. Wisner, K, Perel, J. Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. Psychophamacology (Berl). 1998;18:167–169.Google Scholar
124. Gartner, L. Breastfeeding and the use of human milk. Pediatrics. 1997;100:1035–1039.Google Scholar
125. Ohman, I, Tomson, T, Vitols, S. Lamotrigine levels in plasma and breast milk in nursing women and their infants [Abstract]. Epikpsia. 1998;21(Suppl 2):39.Google Scholar
126. von Unruh, G, Froescher, W, Hoffmann, F, Niesen, M. Valproic acid in breast milk: how much is really there? Ther Drug Monit. 1984;6:272–276.Google Scholar
127. Patrick, M, Tilstone, W, Reavey, P. Diazepam and breastfeeding. Lancet. 1972;l:542–543.Google Scholar
128. Rasgon, N. The relationship between polycystic ovary syndrome and antiepileptic drugs. J Clin Psychopharmacol. 2004;24(3):322–334.Google Scholar
129. Franks, S. Polycystic ovary syndrome. N Engl J Med. 1995;333(13):853–861.Google Scholar
130. Dunaif, A, Thomas, A. Current concepts in the polycystic ovary syndrome. Ann Rev Med. 2001:52:401–419.Google Scholar
131. Wang, JX, Davies, MJ, Norman, RJ. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod. 2001;16(12):2606–2609.Google Scholar
132. Bjercke, S, Dale, PO, Tanbo, T, et al. Impact of insulin resistance on pregancy complications and outcome in women with polycystic ovary syndrome. Gynecol Cfelet Investig. 2002;54(2):94–98.Google Scholar
133. Mikola, M, Hiilesmaa, V, Halttunen, M, et al. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod. 2001;16(2):226–229.Google Scholar
134. Matsunaga, H, Sarai, M. Elevated serum LH and androgens in affective disorder related to the menstrual cycle: with reference to polycystic ovary syndrome. Jpn J Psychiatry Neurol. 1993;47(4):825–842.Google Scholar
135. Rasgon, NL, Altshuler, LL, Gudeman, D, et al. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. J Clin Psychiatry. 2000;61(3):173–178.Google Scholar
136. Isojärvi, JI, Laatikainen, TJ, Pakarinen, AJ, et al. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med. 1993;329(19):1383–1388.Google Scholar
137. Isojärvi, JI, Laatikainen, TJ, Pakarinen, AJ, et al. Menstual disorders in women wiThepilepsy receiving carbamazepine. Epilepsia. 1995;36(7):676–681.Google Scholar
138. Isojärvi, JI, Rattya, J, Myllyla, VV, et al. Valproate, lamotrigine, and insulin-mediated risks in women wiThepilepsy. Ann Neurol. 1998;43(4):446–451.Google Scholar
139. Isojärvi, JI, Laatikainen, TJ, Knip, M, et al. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol. 1996;39(5):579–584.Google Scholar
140. Isojärvi, JI, Tauboll, E, Pakarinen, AJ, et al. Altered ovarian function and cardiovascular risk factors in valproate-treated women. Am J Med. 2001;lll(4):290–296.Google Scholar
141. Akdeniz, F, Taneli, F, Noyan, A, Yuncu, Z, Vahip, S. Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women? Prog Neuropsychopharmocol Biol Psychiatry. 2003;27(1):115–121.Google Scholar